Clinical Oncology
Volume 22, Issue 7 , Pages 586-587 , September 2010

Chemoradiotherapy for Cervical Cancer — Do Questions Remain?

  • L.T. Tan

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: L.T. Tan, Oncology Centre, Box 193, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. Tel: +44-1223-216555; Fax: +44-1223-763120.

Received 3 June 2010 ,Accepted 7 June 2010.

References 

  1. National Cancer Institute . Chemotherapy plus radiation improves survival (press release). Bethesda, MD: National Cancer Institute; 1999;
  2. Tan LT, Russell S, Burgess L. Acute toxicity of chemo-radiotherapy for cervical cancer: the Addenbrooke’s experience. Clin Oncol (R Coll Radiol). 2004;16(4):255–260
  3. Vale CL, Tierney JF, Davidson SE, Drinkwater KJ, Symonds P. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists’ audit. Clin Oncol (R Coll Radiol). 2010;22:
  4. Denton AS, Bond SJ, Matthews S, et al. National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol (R Coll Radiol). 2000;12(6):347–353
  5. Vale C, Nightingale A, Spera N, Whelan A, Hanley B, Tierney JF. Late complications from chemoradiotherapy for cervical cancer: reflections from cervical cancer survivors 10 years after the National Cancer Institute alert. Clin Oncol (R Coll Radiol). 2010;22:
  6. Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst Rev. 2010;(1):CD008285
  7. Department of Health . Health Secretary Outlines Vision for Locally Led NHS Service Changes (press release). London: Department of Health; 2010;

PII: S0936-6555(10)00206-2

doi: 10.1016/j.clon.2010.06.009

Clinical Oncology
Volume 22, Issue 7 , Pages 586-587 , September 2010

Article Tools